S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

ADIL Adial Pharmaceuticals Inc

0.77

0.00 (0.00%)

Mar 05 2025 - Closed

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Adial Pharmaceuticals (NASDAQ:ADIL)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Adial Pharmaceuticals Charts.

Adial Pharmaceuticals (NASDAQ:ADIL)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Adial Pharmaceuticals Charts.

Adial Pharmaceuticals Inc News

Form 8-K - Current report
Tuesday 4 March 2025 (2 days ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Tuesday 4 March 2025 (2 days ago) • Edgar (US Regulatory)

Adial Pharmaceuticals Reports 2024 Fiscal Year Financial Results and Provides Business Update
Tuesday 4 March 2025 (2 days ago) • GlobeNewswire Inc.

Form 8-K - Current report
Tuesday 25 February 2025 (1 week ago) • Edgar (US Regulatory)

Adial Pharmaceuticals Receives Positive Response from FDA Meeting Regarding Proposed In Vitro Bridging Strategy for AD04
Tuesday 25 February 2025 (1 week ago) • GlobeNewswire Inc.

Adial Pharmaceuticals Granted New U.S. Patent Expanding Coverage of its Genetic-Based Approach to Treating and Diagnosing Alcohol Use Disorder and Other Drug Dependencies
Wednesday 19 February 2025 (2 weeks ago) • GlobeNewswire Inc.

Adial Pharmaceuticals Awarded New U.S. Patent Covering Genotype-Specific Treatment of Opioid-Related Disorders
Wednesday 12 February 2025 (3 weeks ago) • GlobeNewswire Inc.

Adial Pharmaceuticals Announces Positive Clinical Study Results from the AD04-103 Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder
Wednesday 29 January 2025 (1 month ago) • GlobeNewswire Inc.

Form 8-K - Current report
Monday 13 January 2025 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 8 January 2025 (2 months ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Tuesday 31 December 2024 (2 months ago) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Monday 30 December 2024 (2 months ago) • Edgar (US Regulatory)

More Adial Pharmaceuticals Inc News Articles

Invesco S&P Internationa...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions